Patients with dementia and agitation are more likely to transition to a more supportive living setting after psychiatric hospitalization.

The FDA will allow several new nicotine pouch products to be marketed as a "lower-risk option" compared with cigarettes.

Supplementation with high-dose docosahexaenoic acid does not improve or change cognitive performance or brain volume over 24 months.

Inadequate built and social environments from birth through childhood may increase the likelihood for depression and anxiety in adolescence.

Improved maternal cardiovascular health is associated with a reduced risk for developmental delay among children at age 4 years.

A new digital mindfulness intervention reduces sleep, anxiety, and depression symptoms among people with late-life depression.

Telehealth-based stepped alcohol treatment is effective for reducing alcohol consumption among people with chronic liver disease.

Many US adults engage with health information on social media but express widespread lack of confidence in its accuracy.

Gastrointestinal interoception me be disrupted among women with anorexia nervosa, compared with those that do not have anorexia nervosa.

Topline data from the phase 3 PALISADE-4 trial showed that fasedienol nasal spray did not significantly improve acute anxiety compared with a placebo in the overall SAD population.

School bullying correlates with depression and internet addiction, but emotional resilience serves as a protective factor for adolescents.

Long-term eptinezumab treatment provides sustained reductions in headache burden for patients with highly refractory chronic migraine.